
Commentary|Podcasts|April 22, 2025
The RIVAWAR Trial and ACS Guidelines for LV Thrombus
Host Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial and the newest ACS guidelines.
Advertisement
Host Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial of rivaroxaban and a discussion of the newest Acute Coronary Syndrome Guidelines for left ventricular thrombus.
For more information:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rocatinlimab Demonstrates Significant Efficacy and Safety in Phase 3 Trials for Moderate-to-Severe Atopic Dermatitis
2
What Pharmacists Should Know About Long COVID and Brain Health
3
Emerging Therapeutic Strategies Transforming Myelofibrosis Care in 2026
4
Circulating Extracellular Vesicles Contribute to Heart Failure Pathogenesis in CKD
5
















